{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T08:53:41Z","timestamp":1769936021177,"version":"3.49.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,24]]},"abstract":"<jats:p>To evaluate radiological and clinical features in metastatic anaplastic lymphoma kinase+ non-small cell lung cancer patients and crizotinib efficacy in different lines. This national, non-interventional, multicenter, retrospective archive screening study evaluated demographic, clinical, and radiological imaging features, and treatment approaches in patients treated between 2013-2017. Totally 367 patients (54.8% males, median age at diagnosis 54 years) were included. Of them, 45.4% were smokers, and 8.7% had a family history of lung cancer. On radiological findings, 55.9% of the tumors were located peripherally, 7.7% of the patients had cavitary lesions, and 42.9% presented with pleural effusion. Pleural effusion was higher in nonsmokers than in smokers (37.3% vs. 25.3%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.018). About 47.4% of cases developed distant metastases during treatment, most frequently to the brain (26.2%). Chemotherapy was the first line treatment in 55.0%. Objective response rate was 61.9% (complete response: 7.6%; partial response: 54.2%). The highest complete and partial response rates were observed in patients who received crizotinib as the 2nd line treatment. The median progression-free survival was 14 months (standard error: 1.4, 95% confidence interval: 11.2\u201316.8 months). Crizotinib treatment lines yielded similar progression-free survival (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.078). The most frequent treatment-related adverse event was fatigue (14.7%). Adrenal gland metastasis was significantly higher in males and smokers, and pleural involvement and effusion were significantly higher in nonsmokers\u2014a novel finding that has not been reported previously. The radiological and histological characteristics were consistent with the literature data, but several differences in clinical characteristics might be related to population characteristics.<\/jats:p>","DOI":"10.1097\/md.0000000000037972","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T18:05:59Z","timestamp":1716573959000},"page":"e37972","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-7390","authenticated-orcid":false,"given":"Saadettin","family":"Kilickap","sequence":"first","affiliation":[{"name":"Department of Preventive Oncology, Hacettepe University Cancer Institute, Ankara, Turkey"},{"name":"Department of Medical Oncology, Istinye University Faculty of Medicine, Istanbul, Turkey"},{"name":"Ankara Liv Hospital, Medical Oncology, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akin","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuri","family":"Karadurmus","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University of Health Sciences Gulhane Training and Research Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taner","family":"Korkmaz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Acibadem University, School of Medicine, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perran Fulden","family":"Yumuk","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey"},{"name":"Medical Oncology Division, Koc University, School of Medicine, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irfan","family":"Cicin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Trakya University Medical Faculty, Edirne, Turkey"},{"name":"Istinye University Medical Center, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semra","family":"Paydas","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Cukurova University Faculty of Medicine, Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebru","family":"Cilbir","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University of Health Sciences Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teoman","family":"Sakalar","sequence":"additional","affiliation":[{"name":"Erciyes University, Faculty of Medicine, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukremin","family":"Uysal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Afyon Kocatepe University Faculty of Medicine, Afyon, Turkey"},{"name":"Medstar Antalya Hospital, Medical Oncology Cancer Center, Antalya, Turkey"},{"name":"Antalya Bilim University, Institute of Health Sciences, Antalya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Havva","family":"Yesil Cinkir","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Gaziantep University Faculty of Medicine, Division of Medical Oncology, Gaziantep, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necdet","family":"Uskent","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necla","family":"Demir","sequence":"additional","affiliation":[{"name":"Sivas Numune Training and Research Hospital, Medical Oncology, Sivas, Turkey"},{"name":"Acibadem Health Group, Kayseri Hospital, Unit of Medical Oncology, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Sakin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Istanbul Prof. Dr. Cemil Tascioglu City Hospital (University of Health Sciences Okmeydani Training and Research Hospital), Istanbul, Turkey"},{"name":"Division of Medical Oncology, Medipol University, Medipol Bahcelievler Hospital, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oldac Uras","family":"Dursun","sequence":"additional","affiliation":[{"name":"Pfizer Oncology, Pfizer, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birkan","family":"Aver","sequence":"additional","affiliation":[{"name":"Pfizer Oncology, Pfizer, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazim Serdar","family":"Turhal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serkan","family":"Keskin","sequence":"additional","affiliation":[{"name":"Department of Oncology, Memorial Sisli Hospital, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Tural","sequence":"additional","affiliation":[{"name":"Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Clinic of Medical Oncology, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesim","family":"Eralp","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey"},{"name":"Acibadem Mehmet Ali Aydinlar University, Institute of Senology, Istanbul, Turkey"},{"name":"Acibadem Healthcare Group, Maslak Hospital, Unit of Medical Oncology, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Bugdayci Basal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ankara Ataturk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey"},{"name":"Department of Medical Oncology, L\u00f6sante Children\u2019s and Adult Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatime Arzu","family":"Yasar","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, L\u00f6sante Children\u2019s and Adult Hospital, Ankara, Turkey"},{"name":"Department of Medical Oncology, Ankara University, Faculty of Medicine, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Ali Nahit","family":"Sendur","sequence":"additional","affiliation":[{"name":"Ankara Atat\u00fcrk Training and Research Hospital, Clinic of Medical Oncology, Ankara, Turkey"},{"name":"Department of Internal Medicine, Medical Oncology Division, Ankara Yildirim Beyazit University, Ankara City Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umut","family":"Demirci","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey"},{"name":"Department of Medical Oncology, Memorial Hospital, Ankara, Turkey"},{"name":"Department of Internal Medicine and Medical Oncology, Medical Sciences Division, Uskudar University, Faculty of Medicine, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdem","family":"Cubukcu","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Medical Oncology, Bursa Uludag University, Faculty of Medicine, Bursa, Turkey"},{"name":"Medicana Health Group-Bursa Hospital, Medical Oncology, Bursa, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Karaagac","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Division of Medical Oncology, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu","family":"Cakar","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Ege University Faculty of Medicine Tulay Aktas Oncology Hospital, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Murat","family":"Tatli","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Division of Medical Oncology, Akdeniz University, Faculty of Medicine, Antalya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarkan","family":"Yetisyigit","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Tekirdag Namik Kemal University, Faculty of Medicine, Tekirdag, Turkey"},{"name":"Department of Medical Oncology, King Hamad University Hospital, Bahrain Oncology Center, Manama, Kingdom of Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semiha","family":"Urvay","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Kayseri Acibadem Hospital, Medical Oncology, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Gursoy","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University of Health Sciences Dr. Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey"},{"name":"Department of Internal Diseases, Medical Oncology Division, Ege University, Faculty of Medicine, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basak","family":"Oyan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Acibadem University, School of Medicine, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep Hande","family":"Turna","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Division of Medical Oncology, Istanbul University Cerrahpasa, Faculty of Medicine, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdurrahman","family":"Isikdogan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dicle University, Faculty of Medicine, Diyarbakir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer Fatih","family":"Olmez","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Medipol University, Faculty of Medicine, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozan","family":"Yazici","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Ankara Numune Training and Research Hospital, Clinic of Medical Oncology, Ankara, Turkey"},{"name":"Department of Internal Diseases, Medical Oncology Division, Gazi University, Faculty of Medicine, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devrim","family":"Cabuk","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Medical Oncology, Kocaeli University Faculty of Medicine, Kocaeli, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Metin","family":"Seker","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Bayindir Hospital Sogutozu, Ankara, Turkey"},{"name":"Department of Medical Oncology, Koru Health Group, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olcun Umit","family":"Unal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey"},{"name":"Department of Medical Oncology-Chemotherapy, University of Health Sciences, Izmir Tepecik Training and Research Hospital, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nezih","family":"Meydan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Adnan Menderes University, Faculty of Medicine, Aydin, Turkey"},{"name":"Department of Medical Oncology, Medicana Health Group, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadi Kerem","family":"Okutur","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Medical Park Bahcelievler Hospital, Istanbul, Turkey"},{"name":"Department of Medical Oncology, Memorial Hospital, Istanbul, Turkey"},{"name":"Department of Medical Oncology, Istanbul Arel University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didem","family":"Tunali","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Koc University, Faculty of Medicine, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Erman","sequence":"additional","affiliation":[{"name":"Departments of Preventive and Medical Oncology, Hacettepe University, Cancer Institute, Ankara, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Lung Sub-Group Study of the Turkish Oncology Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S2213-2600(21)00164-8","article-title":"2019 Respiratory Tract Cancers Collaborators. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"9","year":"2021","journal-title":"Lancet Respir Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"e0257152","DOI":"10.1371\/journal.pone.0257152","article-title":"Development of a novel ALK rearrangement screening test for non-small cell lung cancers.","volume":"16","author":"Chen","year":"2021","journal-title":"PLoS One"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1200\/JCO.2012.46.9270","article-title":"New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.","volume":"31","author":"Travis","year":"2013","journal-title":"J Clin Oncol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer.","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1200\/JCO.2012.44.5353","article-title":"ALK in lung cancer: past, present, and future.","volume":"31","author":"Shaw","year":"2013","journal-title":"J Clin Oncol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2010.09.001","article-title":"Anaplastic lymphoma kinase: role in specific tumours, and development of small molecule inhibitors for cancer therapy.","volume":"299","author":"Ardini","year":"2010","journal-title":"Cancer Lett"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jtho.2019.03.007","article-title":"Updated efficacy and safety data and impact of the EML4-ALK fusion variant on the efficacy of alectinib in untreated ALK-positive advanced non-small cell lung cancer in the Global Phase III ALEX study.","volume":"14","author":"Camidge","year":"2019","journal-title":"J Thorac Oncol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5761\/atcs.oa.14-00093","article-title":"Imaging characteristics in ALK fusion-positive lung adenocarcinomas by using HRCT.","volume":"21","author":"Nakada","year":"2015","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1470-2045(11)70232-7","article-title":"Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.","volume":"12","author":"Shaw","year":"2011","journal-title":"Lancet Oncol"},{"key":"R10-20250504","article-title":"RECIST (Response Evaluation Criteria in Solid Tumours)."},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11523-018-0592-z","article-title":"Characteristics and response to crizotinib in ALK-rearranged, advanced non-adenocarcinoma, non-small cell lung cancer (NA-NSCLC) patients: a retrospective study and literature review.","volume":"13","author":"Zhang","year":"2018","journal-title":"Target Oncol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s11523-017-0520-7","article-title":"Non-small-cell lung cancer (NSCLC) harboring ALK Translocations: clinical characteristics and management in a real-life setting: a French retrospective analysis (GFPC 02-14 study).","volume":"12","author":"Auliac","year":"2017","journal-title":"Target Oncol"},{"key":"R13-20250504","first-page":"CD013453","article-title":"Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.","volume":"1","author":"Cameron","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1148\/radiol.14140848","article-title":"Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.","volume":"275","author":"Choi","year":"2015","journal-title":"Radiology"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1148\/radiol.14140789","article-title":"ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization.","volume":"272","author":"Yamamoto","year":"2014","journal-title":"Radiology"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2214\/AJR.19.21982","article-title":"Imaging features and metastatic patterns of advanced ALK-rearranged non-small cell lung cancer.","volume":"214","author":"Mendoza","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2214\/AJR.19.21485","article-title":"CT characteristics of non-small cell lung cancer with anaplastic lymphoma kinase rearrangement: a systematic review and meta-analysis.","volume":"213","author":"Kim","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"R18-20250504","first-page":"1","article-title":"Non small cell lung cancer with targetable driver alterations: imaging perspective.","volume":"6","author":"Zhang","year":"2019","journal-title":"Integr. Cancer Sci. Ther"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.rmed.2013.11.020","article-title":"Comparison of clinical characteristics between patients with ALK-positive and EGFR-positive lung adenocarcinoma.","volume":"108","author":"Kang","year":"2014","journal-title":"Respir Med"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.lungcan.2014.09.007","article-title":"Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?","volume":"86","author":"Halpenny","year":"2014","journal-title":"Lung Cancer"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3389\/fonc.2019.01116","article-title":"Real world experience of crizotinib in 104 patients with ALK rearrangement non-small-cell lung cancer in a single chinese cancer center.","volume":"9","author":"Liu","year":"2019","journal-title":"Front Oncol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"FSO394","DOI":"10.2144\/fsoa-2019-0017","article-title":"The effects of cigarette smoking extracts on cell cycle and tumor spread: novel evidence.","volume":"5","author":"Pezzuto","year":"2019","journal-title":"Future Sci OA"},{"key":"R23-20250504","first-page":"4343","article-title":"Effect of smoking on experimental malignant pleural effusion.","volume":"46","author":"Magkouta","year":"2015","journal-title":"Eur Respir J"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/JTO.0b013e31815e8b60","article-title":"EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.","volume":"3","author":"Inamura","year":"2008","journal-title":"J Thorc Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fonc.2020.01299","article-title":"Real-world treatment patterns and survival outcome in advanced anaplastic lymphoma kinase (ALK) rearranged non-small-cell lung cancer patients.","volume":"10","author":"Britschgi","year":"2020","journal-title":"Front Oncol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2147\/CLEP.S69718","article-title":"Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors.","volume":"6","author":"Chia","year":"2014","journal-title":"Clin. Epidemiol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3904\/kjim.2018.011","article-title":"Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer.","volume":"34","author":"Ock","year":"2019","journal-title":"Korean J Intern Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.","volume":"363","author":"Kwak","year":"2010","journal-title":"N Engl J Med"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1470-2045(12)70344-3","article-title":"Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.","volume":"13","author":"Camidge","year":"2012","journal-title":"Lancet Oncol"},{"issue":"15_Suppl","key":"R30-20250504","doi-asserted-by":"crossref","first-page":"Abstract 7514","DOI":"10.1200\/jco.2011.29.15_suppl.7514","article-title":"Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005.","volume":"29","author":"Crin\u00f2","year":"2011","journal-title":"J Clin Oncol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","article-title":"Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.","volume":"368","author":"Shaw","year":"2013","journal-title":"N Engl J Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1200\/JCO.2017.77.4794","article-title":"Final overall survival analysis from a study comparing first-line crizotinib versus chemotherapy in ALK-mutation-positive non-small-cell lung cancer.","volume":"36","author":"Solomon","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:55:35Z","timestamp":1746320135000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":32,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037972","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]}}}